Genmab A/S Directors Remuneration Expense
Genmab A/S (GNMSF) reported Directors Remuneration Expense of DKK 122.00 million for the 12-month period ending 2021-12-31, per its 6-K filed 2022-02-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DirectorsRemunerationExpense · last filed 2022-02-16
| Period end | Directors Remuneration Expense 12 month |
|---|---|
| 2021-12-31 | 122.00M DKK 6-K · filed 2022-02-16 |
| 2020-12-31 | 119.00M DKK 6-K · filed 2022-02-16 |
| 2019-12-31 | 96.00M DKK 6-K · filed 2022-02-16 |
| 2018-12-31 | 86.00M DKK 6-K · filed 2021-02-23 |
| 2017-12-31 | 64.00M DKK 20-F · filed 2020-03-30 |